Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 D1 receptor antagonists in schizophrenia.

× No keyword cloud information.

15 in total

1. Tolerability, safety and pharmacokinetics of single dose and multiple dosing of the selective D1 antagonist NNC 01-0687 in healthy subjects.

Authors: B K Skrumsager; J V Christensen; S Snel; M Seiberling
Journal: Psychopharmacology (Berl) Date: 1995-10 Impact factor: 4.530

2. NNC 01-0687, a selective dopamine D1 receptor antagonist, in the treatment of schizophrenia.

Authors: J Karle; L Clemmesen; L Hansen; M Andersen; J Andersen; C Fensbo; M Sloth-Nielsen; B K Skrumsager; H Lublin; J Gerlach
Journal: Psychopharmacology (Berl) Date: 1995-10 Impact factor: 4.530

3. Effect of chronic treatment with NNC 756, a new D-1 receptor antagonist, or raclopride, a D-2 receptor antagonist, in drug-naive Cebus monkeys: dystonia, dyskinesia and D-1/D-2 supersensitivity.

Authors: J Gerlach; L Hansen
Journal: J Psychopharmacol Date: 1993-01 Impact factor: 4.153

4. The risks and benefits of clozapine versus chlorpromazine.

Authors: J Claghorn; G Honigfeld; F S Abuzzahab; R Wang; R Steinbook; V Tuason; G Klerman
Journal: J Clin Psychopharmacol Date: 1987-12 Impact factor: 3.153

5. Selective D1- and D2-dopamine receptor blockade both induces akathisia in humans--a PET study with [11C]SCH 23390 and [11C]raclopride.

Authors: L Farde
Journal: Psychopharmacology (Berl) Date: 1992 Impact factor: 4.530

6. Dopamine D1 (SCH 23390) and D2 (haloperidol) antagonists in drug-naive monkeys.

Authors: D E Casey
Journal: Psychopharmacology (Berl) Date: 1992 Impact factor: 4.530

7. An open trial of the D1 antagonist SCH 39166 in six cases of acute psychotic states.

Authors: R de Beaurepaire; A Labelle; D Naber; B D Jones; T R Barnes
Journal: Psychopharmacology (Berl) Date: 1995-10 Impact factor: 4.530

8. The effects of D1 (NNC 22-0215) and D2 (haloperidol) antagonists in a chronic double-blind placebo controlled trial in cebus monkeys.

Authors: D E Casey
Journal: Psychopharmacology (Berl) Date: 1995-10 Impact factor: 4.530

9. Evaluation of SCH 39166 as PET ligand for central D1 dopamine receptor binding and occupancy in man.

Authors: P Karlsson; G Sedvall; C Halldin; C G Swahn; L Farde
Journal: Psychopharmacology (Berl) Date: 1995-10 Impact factor: 4.530

10. Lack of apparent antipsychotic effect of the D1-dopamine receptor antagonist SCH39166 in acutely ill schizophrenic patients.

Authors: P Karlsson; L Smith; L Farde; C Härnryd; G Sedvall; F A Wiesel
Journal: Psychopharmacology (Berl) Date: 1995-10 Impact factor: 4.530